Heat Biologics' Merger Partner Elusys Finalizes HHS Contract For Its Anthrax Treatment
Heat Biologics Issues New PTX-35 Preclinical Data In Organ Transplantation, Update On HS-110
Heat Biologics To Bolster Presence In Biodefense Space With Elusys Acquisition
Heat Biologics Is Starting To Run Away From Support Toward Resistance
HTBX Stock Price: 40.15% Increase Explanation
Heat Biologics Surges On Patent Filing
Heat Biologics' Lead Candidate Shows Overall Survival Benefit In Lung Cancer Study
HTBX Stock Price Increases Over 25% Pre-Market: Why It Happened
HTBX Stock Price Increased 103.1% In Day High: Why It Happened
Heat Biologics stock more than doubles after 'positive' trial data of its lung cancer treatment
Heat Biologics Cell Therapy Shows Survival Benefit In Mid-Stage Lung Cancer Study, Shares Rally
HTBX Stock Price Increases Over 6% Pre-Market: Why It Happened